Literature DB >> 24785206

Diagnosis of childhood tuberculosis and host RNA expression in Africa.

Suzanne T Anderson, Myrsini Kaforou, Andrew J Brent, Victoria J Wright, Lachlan J Coin, Robert S Heyderman, Michael Levin, Brian Eley, Claire M Banwell, George Chagaluka, Amelia C Crampin, Hazel M Dockrell, Neil French, Melissa S Hamilton, Martin L Hibberd, Florian Kern, Paul R Langford, Ling Ling, Rachel Mlotha, Tom H M Ottenhoff, Sandy Pienaar, Vashini Pillay, J Anthony G Scott, Hemed Twahir, Robert J Wilkinson.   

Abstract

BACKGROUND: Improved diagnostic tests for tuberculosis in children are needed. We hypothesized that transcriptional signatures of host blood could be used to distinguish tuberculosis from other diseases in African children who either were or were not infected with the human immunodeficiency virus (HIV).
METHODS: The study population comprised prospective cohorts of children who were undergoing evaluation for suspected tuberculosis in South Africa (655 children), Malawi (701 children), and Kenya (1599 children). Patients were assigned to groups according to whether the diagnosis was culture-confirmed tuberculosis, culture-negative tuberculosis, diseases other than tuberculosis, or latent tuberculosis infection. Diagnostic signatures distinguishing tuberculosis from other diseases and from latent tuberculosis infection were identified from genomewide analysis of RNA expression in host blood.
RESULTS: We identified a 51-transcript signature distinguishing tuberculosis from other diseases in the South African and Malawian children (the discovery cohort). In the Kenyan children (the validation cohort), a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (95% confidence interval [CI], 68.6 to 94.3) and a specificity of 83.6% (95% CI, 74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis. Among patients with cultures negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probable, probable, or possible cases of tuberculosis), the estimated sensitivity was 62.5 to 82.3%, 42.1 to 80.8%, and 35.3 to 79.6%, respectively, for different estimates of actual tuberculosis in the groups. In comparison, the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (95% CI, 37.1 to 68.6), and the sensitivity in highly probable, probable, or possible cases was an estimated 25.0 to 35.7%, 5.3 to 13.3%, and 0%, respectively; the specificity of the assay was 100%.
CONCLUSIONS: RNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection. (Funded by the European Union Action for Diseases of Poverty Program and others).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24785206      PMCID: PMC4069985          DOI: 10.1056/NEJMoa1303657

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  32 in total

1.  Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis.

Authors:  Rohit Mistry; Jacqueline M Cliff; Christopher L Clayton; Nulda Beyers; Yasmin S Mohamed; Paul A Wilson; Hazel M Dockrell; Don M Wallace; Paul D van Helden; Ken Duncan; Pauline T Lukey
Journal:  J Infect Dis       Date:  2006-12-21       Impact factor: 5.226

2.  The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Authors:  Shingai Machingaidze; Charles Shey Wiysonge; Yulieth Gonzalez-Angulo; Mark Hatherill; Sizulu Moyo; Willem Hanekom; Hassan Mahomed
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

3.  Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study.

Authors:  Chifumbe Chintu; Victor Mudenda; Sebastian Lucas; Andrew Nunn; Kennedy Lishimpi; Daniel Maswahu; Francis Kasolo; Peter Mwaba; Ganapati Bhat; Hiroshi Terunuma; Alimuddin Zumla
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

4.  Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.

Authors:  Heather J Zar; David Hanslo; Patricia Apolles; George Swingler; Gregory Hussey
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

5.  Common patterns and disease-related signatures in tuberculosis and sarcoidosis.

Authors:  Jeroen Maertzdorf; January Weiner; Hans-Joachim Mollenkopf; Torsten Bauer; Antje Prasse; Joachim Müller-Quernheim; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

Review 6.  Diagnosis of pulmonary tuberculosis in children: new advances.

Authors:  Heather J Zar; Tom G Connell; Mark Nicol
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.

Authors:  B Kampmann; E Whittaker; A Williams; S Walters; A Gordon; N Martinez-Alier; B Williams; A M Crook; A-M Hutton; S T Anderson
Journal:  Eur Respir J       Date:  2009-02-05       Impact factor: 16.671

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children.

Authors:  Lilly M Verhagen; Aldert Zomer; Mailis Maes; Julian A Villalba; Berenice Del Nogal; Marc Eleveld; Sacha Aft van Hijum; Jacobus H de Waard; Peter Wm Hermans
Journal:  BMC Genomics       Date:  2013-02-01       Impact factor: 3.969

View more
  140 in total

Review 1.  Update in Mycobacterium tuberculosis lung disease 2014.

Authors:  Paul Elkington; Alimuddin Zumla
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

2.  To build better tuberculosis diagnostics, look for 'biosignatures'.

Authors:  Alan Dove
Journal:  Nat Med       Date:  2015-07       Impact factor: 53.440

3.  Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.

Authors:  Takele Teklu; Keehwan Kwon; Biniam Wondale; Milkessa HaileMariam; Aboma Zewude; Girmay Medhin; Mengistu Legesse; Rembert Pieper; Gobena Ameni
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children.

Authors:  Rewa K Choudhary; Kristin M Wall; Irene Njuguna; Patricia B Pavlinac; Sylvia M LaCourse; Vincent Otieno; John Gatimu; Joshua Stern; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Grace John-Stewart; Lisa M Cranmer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

5.  Serologic Responses in Childhood Pulmonary Tuberculosis.

Authors:  Bareng A S Nonyane; Mark P Nicol; Nicholas J Andreas; Stefanie Rimmele; Nicole Schneiderhan-Marra; Lesley J Workman; Mark D Perkins; Thomas Joos; Tobias Broger; Jerrold J Ellner; David Alland; Beate Kampmann; Susan E Dorman; Heather J Zar
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129

Review 6.  Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches.

Authors:  Michael L McHenry; Scott M Williams; Catherine M Stein
Journal:  Infect Genet Evol       Date:  2020-01-22       Impact factor: 3.342

7.  Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis.

Authors:  Timothy E Sweeney; Lindsay Braviak; Cristina M Tato; Purvesh Khatri
Journal:  Lancet Respir Med       Date:  2016-02-20       Impact factor: 30.700

8.  Diagnostic value of blood gene expression signatures in active tuberculosis in Thais: a pilot study.

Authors:  N Satproedprai; N Wichukchinda; S Suphankong; W Inunchot; T Kuntima; S Kumpeerasart; S Wattanapokayakit; S Nedsuwan; H Yanai; K Higuchi; N Harada; S Mahasirimongkol
Journal:  Genes Immun       Date:  2015-03-12       Impact factor: 2.676

Review 9.  Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.

Authors:  Madhukar Pai; Marco Schito
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

10.  Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis.

Authors:  Santtu Heinonen; Tuomas Jartti; Carla Garcia; Silvia Oliva; Cynthia Smitherman; Esperanza Anguiano; Wouter A A de Steenhuijsen Piters; Tytti Vuorinen; Olli Ruuskanen; Blerta Dimo; Nicolas M Suarez; Virginia Pascual; Octavio Ramilo; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-04-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.